Pathogenetic therapeutic tactics in case of true gynecomastia
https://doi.org/10.17650/1994-4098-2013-0-1-2-35-39
Abstract
The characteristics of the treatment tactics of the non-nodular forms of gynecomastia as mammary gland’s cancer prevention is given in the ar- ticle on the basis of the own observations and the example of the work of domestic and foreign authors. Variants of the mono- and combined drug therapy are analyzed. Treatment results are given. An attempt was made to determine the priority of the treatment variants being used.
About the Authors
V. A. Ivanov
Department of the Ultrasound Diagnostics and Surgery, Faculty for Postgraduate Training of Medical Workers, People's Friendship University of Russia, Moscow
Russian Federation
Russian Federation
I. A. Ozerskaya
Department of the Ultrasound Diagnostics and Surgery, Faculty for Postgraduate Training of Medical Workers, People's Friendship University of Russia, Moscow
Russian Federation
Russian Federation
D. V. Akimov
Clinical and Diagnostic Centre number 4, Moscow Healthcare Department
Russian Federation
Russian Federation
References
1. Макимбетов Э.К., Головачев С.В., Султангазиева Б.Б. Эпидемиология рака грудной железы у мужчин в Кыргызстане. Вестн Рос асс радиол 2009;(1):203–4.
2. Gruntmanis U., Braunstein G.D. Treatment of gynecomastia. Curr Opin Investig Drugs 2001;2(5):643–9.
3. Ветшев П.С., Чилингариди К.Е., Новосёлова Н.В. Гинекомастия – клиника, диагностика и лечение. Хирургия 2002;(2):59–65.
4. Wilson J.D., Aiman J., McDonald P.C. The pathogenesis of gynecomastia. Adv Intern Med 1980;25:1–32.
5. Тарутинов В.И., Лигирда О.Ф. Тактика лечения дисгормональных гиперплазий молочных желез с учетом патогенетических механизмов развития заболевания. Азерб журн онкол и смежн наук 2006;10(1):98–106.
6. Луценко А.Г. Пубертатная гинекомастия. Дис. ... канд. мед. наук. Киев, 1991. 109 с.
7. Тарутинов В.И., Маевская Л.П., Федорова Л.В. и др. Функциональное состояние гипофиза, коры надпочечников и гонад у больных гинекомастией. Вопр онкол 1991;37(5):576–9.
8. Ball R.K., Friis R.R., Schoenenberger C.A. et al. Prolactin regulation of beta-casein gene expression and of a cytosolic 120-kd protein in a cloned mouse mammary epithelial cell line. EMBO J 1988;7(7):2089–95.
9. Ambrosi B., Travaglini P., Beck-Peccoz P. et al. Effect of sulpiride-induced hyperprolactinemia on serum testosterone response to HCG in normal men. J Clin Endocrinol Metab 1976;43(3):700–3.
10. Laituri C.A., Garey C.L., Ostlie D.J. et al. Treatment of adolescent gynecomastia. J Pediatr Surg 2010;45(3):650–4.
11. Carlson H.E. Approach to the patient with gynecomastia. J Clin Endocrinol Metab 2011;96(1):15–21.
12. Алиев Д.А., Розин Д.Л. Рентгенодиаг- ностика и лечение диспластических процессов в молочной железе. ХІ Всесоюз- ный съезд рентгенологов и радиологов, 1987. С. 52–62.
Review
For citations:
Ivanov V.A., Ozerskaya I.A., Akimov D.V. Pathogenetic therapeutic tactics in case of true gynecomastia. Tumors of female reproductive system. 2013;(1-2):35-39. (In Russ.) https://doi.org/10.17650/1994-4098-2013-0-1-2-35-39
Views:
559
Email this article 